KKR has led a $75 million series B funding round in Digital Diagnostics, a specialist in AI healthcare diagnosis. Investors including Cedar Pine, Kinderhook, 8VC, Optum Ventures, OSF Ventures and the University of Iowa also took part in the round.
The latest funding has almost doubled the company’s total outside capital raised to $130 million.
In January, KKR closed its Health Care Strategic Growth Fund II on $4 billion, almost three-times bigger that it’s previous healthcare fund which closed with $1.45bn in capital commitments.
Galderma Group AG agreed to acquire ZO Skin Health Inc. from Blackstone Tactical Opportunities and the Obagi family for an enterprise value of $1.5 billion. The all-cash transaction buys a...
BlackRock entered an agreement on October 13, 2026, to acquire the majority equity stake in a primary care joint venture from Welsh, Carson, Anderson & Stowe for $2.8 billion. The transaction...
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
